ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,809Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 978

$679K Total Retail Price of All Prescriptions

Rank: 18 out of 978

465 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

14% of this provider’s 465 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

3% of this provider’s 15,730 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
LISINOPRIL 1,099 936 1 1
LOVASTATIN 1,077 924 2 29
ALENDRONATE SODIUM 747 697 3 20
OMEPRAZOLE 744 626 4 3
SIMVASTATIN 694 595 5 2
HYDROCHLOROTHIAZIDE 538 502 6 5
METOPROLOL TARTRATE 537 478 7 10
FUROSEMIDE 496 472 8 9
GLYBURIDE 417 368 R 9 44
METFORMIN HCL 395 318 10 7
HYDROCODONE-ACETAMINOPHEN 385 319 S3 11 17
LEVOTHYROXINE SODIUM 373 260 12 4
AMLODIPINE BESYLATE 343 325 13 6
CRESTOR 299 258 14 30
PANTOPRAZOLE SODIUM 297 253 15 39
ATENOLOL 286 261 16 8
WARFARIN SODIUM 273 256 17 11
ATORVASTATIN CALCIUM 252 221 18 12
FENOFIBRATE 234 205 19 53
METOPROLOL SUCCINATE 232 217 20 13
TRAZODONE HCL 225 201 21 18
CITALOPRAM HBR 206 175 22 14
PRAVASTATIN SODIUM 203 175 23 16
PROAIR HFA 201 148 24 19
MECLIZINE HCL 188 180 25 120
ALLOPURINOL 177 173 26 34
ATENOLOL-CHLORTHALIDONE 169 145 27 134
LOSARTAN POTASSIUM 157 156 28 22
TERAZOSIN HCL 154 149 29 76
GABAPENTIN 154 150 29 15
TRAMADOL HCL 146 146 31 24
JANUVIA 133 130 32 82
FLUOXETINE HCL 115 86 33 42
SERTRALINE HCL 102 99 34 21
NEXIUM 101 92 35 77
PAROXETINE HCL 97 69 36 52
DIOVAN 96 78 37 43
ISOSORBIDE MONONITRATE ER 92 92 38 57
CLOPIDOGREL 87 67 39 61
TRICOR 84 73 40 144
CARVEDILOL 83 81 41 55
TAMSULOSIN HCL 82 70 42 33
DIGOXIN 82 70 42 54
MELOXICAM 80 74 44 112
ZOLPIDEM TARTRATE 80 69 44 32
NAPROXEN 80 58 44 73
WELCHOL 78 72 47 283
JANTOVEN 77 77 48 184
DILTIAZEM 24HR ER 75 65 49 69
SPIRIVA 74 69 50 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 71 59 51 36
ZETIA 69 67 52 109
RANITIDINE HCL 68 66 53 27
POLYETHYLENE GLYCOL 3350 66 63 54 58
GEMFIBROZIL 65 65 55 97
KLOR-CON M20 65 65 55 66
POTASSIUM CHLORIDE 64 50 57 41
PLAVIX 64 56 57 96
DOXAZOSIN MESYLATE 62 62 59 90
LOVAZA 59 57 60 156
LOSARTAN-HYDROCHLOROTHIAZIDE 57 50 61 122
CLOTRIMAZOLE-BETAMETHASONE 55 44 62 165
NIASPAN 54 42 63 158
DILTIAZEM 24HR CD 53 52 64 111
ADVAIR DISKUS 52 44 65 35
PREDNISONE 52 40 65 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 1, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.